Literature DB >> 16716374

Genetic analysis of poxvirus mRNA cap methyltransferase: suppression of conditional mutations in the stimulatory D12 subunit by second-site mutations in the catalytic D1 subunit.

Beate Schwer1, Stewart Shuman.   

Abstract

The guanine-N7 methyltransferase domain of vaccinia virus mRNA capping enzyme, composed of catalytic vD1(498-844) and stimulatory vD12 subunits, can function in vivo in Saccharomyces cerevisiae in lieu of the essential cellular cap methyltransferase Abd1. Coexpression of both poxvirus subunits is required to complement the growth of abd1Delta cells. A double-alanine scan of the vD12 protein identified lethal and temperature-sensitive vD12 alleles. We used this mutant collection to perform a forward genetic screen for compensatory changes in the catalytic subunit that suppressed the growth phenotypes of the vD12 mutants. The screen reiteratively defined a small ensemble of amino acids in vD1(498-844) at which mutations restored methyltransferase function in conjunction with defective vD12 proteins. Reference to the crystal structure of the microsporidian cap methyltransferase suggests that distinct functional classes of suppressors were selected, including: (i) those that map to surface-exposed loops, which likely comprise the physical subunit interface; (ii) those in or near the substrate binding sites, which presumably affect or mimic inter-subunit allostery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16716374     DOI: 10.1016/j.virol.2006.03.050

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Structure and Biochemical Characteristic of the Methyltransferase (MTase) Domain of RNA Capping Enzyme from African Swine Fever Virus.

Authors:  Xuejian Du; Zeng-Qiang Gao; Zhi Geng; Yu-Hui Dong; Heng Zhang
Journal:  J Virol       Date:  2020-12-02       Impact factor: 5.103

2.  Structural insights into the mechanism and evolution of the vaccinia virus mRNA cap N7 methyl-transferase.

Authors:  Marcos De la Peña; Otto J P Kyrieleis; Stephen Cusack
Journal:  EMBO J       Date:  2007-11-08       Impact factor: 11.598

3.  Phenotypic analysis of a temperature sensitive mutant in the large subunit of the vaccinia virus mRNA capping enzyme.

Authors:  Amber N Shatzer; Sayuri E M Kato; Richard C Condit
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

4.  Crystal structure of vaccinia virus mRNA capping enzyme provides insights into the mechanism and evolution of the capping apparatus.

Authors:  Otto J P Kyrieleis; Jonathan Chang; Marcos de la Peña; Stewart Shuman; Stephen Cusack
Journal:  Structure       Date:  2014-03-04       Impact factor: 5.006

5.  Structure-function analysis of severe acute respiratory syndrome coronavirus RNA cap guanine-N7-methyltransferase.

Authors:  Yu Chen; Jiali Tao; Ying Sun; Andong Wu; Ceyang Su; Guozhen Gao; Hui Cai; Su Qiu; Yingliang Wu; Tero Ahola; Deyin Guo
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

6.  Comparative whole genome sequence analysis of wild-type and cidofovir-resistant monkeypoxvirus.

Authors:  Jason Farlow; Mohamed Ait Ichou; John Huggins; Sofi Ibrahim
Journal:  Virol J       Date:  2010-05-28       Impact factor: 4.099

7.  Mutational analysis of vaccinia virus mRNA cap (guanine-N7) methyltransferase reveals essential contributions of the N-terminal peptide that closes over the active site.

Authors:  Sushuang Zheng; Stewart Shuman
Journal:  RNA       Date:  2008-09-17       Impact factor: 4.942

8.  Structure-function analysis of vaccinia virus mRNA cap (guanine-N7) methyltransferase.

Authors:  Sushuang Zheng; Stewart Shuman
Journal:  RNA       Date:  2008-02-06       Impact factor: 4.942

9.  Biochemical analysis of the multifunctional vaccinia mRNA capping enzyme encoded by a temperature sensitive virus mutant.

Authors:  Jessica Tate; Rachel L Boldt; Baron D McFadden; Susan M D'Costa; Nicholas M Lewandowski; Amber N Shatzer; Paul Gollnick; Richard C Condit
Journal:  Virology       Date:  2015-10-20       Impact factor: 3.616

Review 10.  Orthopoxvirus targets for the development of new antiviral agents.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Antiviral Res       Date:  2012-03-08       Impact factor: 10.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.